Showing results (1751-1760 of 2,017) with videos related to

Sort By:
Pageof 202
Open Forum Infectious Diseases|May 5, 2025
The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir ProphylaxisCorrado Girmenia, Patrizia Chiusolo, Giovanni Marsili, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter SurveyCorrado Girmenia, Alice Bertaina, Alfonso Piciocchi, et al.
Plants (Basel, Switzerland)|July 15, 2026
Title Effects of Antioxidant Treatments on Sprouting, Survival, Callus Formation, and Attempted Adventitious Rooting of Campomanesia adamantium Cuttings Across Different SeasonsGustavo Henrique Oliveira Lira Chaves, Luiz Henrique Rodrigues Guimarães, Romário Ferreira Cesário, et al.
Haematologica|January 29, 2026
GVHD and GRFS in patients with acute myeloid leukemia undergoing allogeneic HCT with treosulfan- versus reduced-intensity busulfan-based conditioning: a subgroup analysis of a randomized phase 3 trialFriedrich Stölzel, Matthias Stelljes, Dietrich Wilhelm Beelen, et al.
Blood Cancer Journal|August 21, 2024
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trialGianluca Cavallaro, Anna Grassi, Chiara Pavoni, et al.
Leukemia|March 22, 2017
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring SystemM G Della Porta, C H Jackson, E P Alessandrino, et al.
Transplantation Direct|February 27, 2023
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld StudyMichele Malagola, Nicola Polverelli, Massimo Martino, et al.
Transplantation and Cellular Therapy|November 24, 2021
GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and CriticismsMichele Malagola, Nicola Polverelli, Vicky Rubini, et al.
Annals of Hematology|January 21, 2026
Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational studyAnna Paola Iori, Antonio De Vivo, Eros Di Bona, et al.
International Journal of Radiation Oncology, Biology, Physics|August 9, 2024
Refining Treatment Planning in STereotactic Arrhythmia Radioablation: Benchmark Results and Consensus Statement From the STOPSTORM.eu ConsortiumValeria Trojani, Melanie Grehn, Andrea Botti, et al.
Pageof 202